Gretchen brings over a decade of experience bridging science and strategy to back transformative health technologies. She holds a BSc and MS in Molecular Biology and Biomedical Research from the University of Queensland, Australia, and earned her PhD in Neuroepigenetics from ETH Zürich.

With a career spanning academia, philanthropy, Family Office and Venture Capital investing, she brings a unique vantage point on how to identify and support high-value healthcare innovations. She served on the board of 2 privately held biotech companies and is dedicated to crafting bold strategies, building world-class networks, and scaling a Healthtech portfolio anchored in the Swiss and European ecosystem.

At her core, she’s passionate about health, innovation, and connecting with visionary founders and partners who are shaping the future of healthcare.